Hospice News December 30, 2025
The winds have changed in the hospice merger and acquisition landscape in 2025. Activity slumped as the year began, but picked up steam as more strategic acquisitions unfolded, particularly in the fourth quarter.
A number of factors created a lull in M&A activity in the beginning of this year, with uncertainty a common thread woven among issues related to economic, reimbursement, regulatory and operational challenges. Another commonality was the careful approach in strategic deal-making taken among both buyers and sellers alike.
Hospice merger-and-acquisition activity saw a significant rebound in the fourth quarter, delivering the strongest deal volume the industry has experienced since 2021. The M&A advisory firm Mertz Taggart reported 16 hospice transactions to date in Q4, a notable increase...
Today's Sponsors
Today's Sponsor